Biotheranostics Company
Biotheranostics discovers and develops proprietary molecular-based tests that provide physicians with actionable information to help guide cancer treatment.
%20.jpg)
Founded Date:
01-01-1996
Total Funding:
$32,000,000
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
M&A
Technology:
Digital Healthcare
Last Funding Type:
Venture - Series Unknown
Investors Number:
3
Last Funding Date:
2016-01-21
Industry:
General Health Care
Headquarters:
San Diego, California, United States
Estimated Revenue:
$10M to $50M